switching from zepbound to compounded tirzepatide CAUTION: Compound One Month Later w/ 7 Changes! // LMNT FDA Allows Compounded Tirzepatide During
Description
2014, pp

These benefits can profoundly influence overall wellness and reduce the risk of weight-related health conditions

Laboratory Abnormalities Amylase and Lipase Increase In clinical trials, treatment with ZEPBOUND resulted in mean increases from baseline in serum pancreatic amylase concentrations of 20% to 25% and serum lipase concentrations of 28% to 35%, compared to mean increases from baseline in pancreatic amylase of 2.1% and serum lipase of 5.8% in placebo-treated patients
These are not minor issues

Many providers address this by starting patients on 10mg/ml vials and transitioning to 20mg/ml vials once they reach the 10mg dose level

Evaluate your activity level
